Elite's SEQUESTOX approval could be as close as March 2017 if Elite does not have major hurdles or may be as are far out as September 2017 depending on time for fed BE study.
I believe it will be the sooner timeframe.
Nasrat himself said he would "target" 2017 for resubmission, but yet you believe it will not only be resubmitted but also approved by March 2017. He said they have work to do and then a fed a bioequivalence study, and none of that will even start to be planned until 3rd week in December. You predict they will complete the work and the BE study by then end of January (5 weeks!) and will be granted a 60 day review so that it can be approved by end of March? Pure fantasy, and not the good kind.
March 2018, maybe, but even that seems optimistic to me. And I'd much rather have a quality product that docs will prescribe in mid-2018 rather than a piece of crap in early 2017 that will be the laughing stock of the medical community. Fix the bead, Nasrat. Make it right. Be the tortoise.